Evidence Hub

Antibacterial activity study (in silico & in vitro) of some coumarin molecules as ligands against streptococcus pyogenes bacteria

Abdalkader Saeed Latif, Ihab Q. Ali, Ammar Basim Al-Asadi, Shahla Hussien Huno

Eastern Ukrainian Medical Journal, 2025

Abstract

Background: Coumarin derivatives have emerged as a potential antimicrobial agent due to their broad spectrum of biological activities. Objective: Antibacterial activity against Streptococcus pyogenes is analyzed by the study of binding potentials and efficiencies of five coumarin ligands (L1, L2, L3, L4, L5) were compared to the conventional antibiotic. Clinical samples were collected from Iraqi patients attending the teaching hospital from June to October of 2023. Streptococcus pyogenes was isolated and characterized; 23 of these were confirmed by the VITEK 2 system. The susceptibility testing of the different isolated bacteria to a range of antibiotics, including Sulfamethoxazole, was carried out using the disc diffusion. Methods: The resistant ones were further tested with the coumarin molecules ligands (L1, L2, L3, L4, L5) using the agar well diffusion method. Results: Ligand number L3 showed the highest binding affinity for the Streptococcus pyogenes enzyme glycosyltransferase with a binding energy of (-38.7 Kcal/mol), representing the strong inhibiting potential of the drug. Resistance in clinical isolates was 32% to Sulfamethoxazole and showed variable susceptibility patterns to other antibiotics tested. Among these resistant strains, L3 has shown the strongest antibacterial activity, its MIC equal to (256 µg/ml), exceeding Sulfamethoxazole, while on the other hand, ligands L1, L4, and L5 gave moderate antibacterial activities, while L2, on the other hand, was found…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free